No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
WGS240719C25000
- 2.35
- -1.95-45.35%
15min DelayClose Jun 28 16:00 ET
2.39High2.34Low
2.39Open4.30Pre Close76 Volume71 Open Interest25.00Strike Price17.80KTurnover102.74%IV4.63%PremiumJul 19, 2024Expiry Date1.14Intrinsic Value100Multiplier19DDays to Expiry1.21Extrinsic Value100Contract SizeAmericanOptions Type0.6250Delta0.0615Gamma8.57Leverage Ratio-0.0635Theta0.0070Rho5.36Eff Leverage0.0228Vega
Intraday
- 5D
- Daily
News
Form 144(Amend) | GeneDx Holdings(WGS.US) 10% Stockholder Proposes to Sell 36.49 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $GeneDx Holdings(WGS.US)$、$GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 1.37 million shares of its co
Form 144 | GeneDx Holdings(WGS.US) 10% Stockholder Proposes to Sell 6.96 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 28, $GeneDx Holdings(WGS.US)$、$GENEDX HOLDINGS CORP C/WTS 22/07/2026 (TO PUR COM)(WGSWW.US)$ 10% Stockholder OPKO HEALTH, INC. intends to sell 261.42K shares of its common
GeneDx Holdings Is Maintained at Buy by BTIG
BTIG Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $35
GeneDx Hldgs Analyst Ratings
Express News | GeneDx Holdings Corp : Btig Raises Target Price to $35 From $19
Comments
Hello Mooers! ![]()
A quick recap for the month ending April 30, 2024.
![]()
Ten stocks with >300% YTD
![]()
$Swvl Holdings(SWVL.US$718.40%
![]()
$Root Inc(ROOT.US$564.60%
![]()
$Elevation Oncology(ELEV.US$561.08%
![]()
$JanOne(JAN.US$554.05%
![]()
$GeneDx Holdings(WGS.US$520.71%
![]()
$Corbus Pharmaceuticals(CRBP.US$513.25%
![]()
$AGBA Group(AGBA.US$482.90%
![]()
$Janux Therapeutics(JANX.US$431.22%
![]()
$Dave Inc(DAVE.US$4...
A quick recap for the month ending April 30, 2024.
4
1
$GeneDx Holdings(WGS.US$
NEWS
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
NEWS
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
1
The low P/S of GeneDx Holdings indicates investors expect limited future growth. A recent share price boost hasn't shifted investor perceptions. The low P/S is largely because shareholders are pessimistic about revenue prospects.
Read more
Mars MoooOP :